[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355191-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355191-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","integrative-genomic-profiling-of-pediatric-solid-tumors-reveals-clinically-relevant-variants-and-chromosomal-arm-aneuploidies-signatures","Integrative Genomic Profiling of Pediatric Solid Tumors Reveals Clinically Relevant Variants and Chromosomal Arm Aneuploidies Signatures","","Study investigates molecular features of Chinese pediatric solid tumors that remain insufficiently characterized despite genomic advances. Targeted next-generation sequencing of 94 tumors evaluates single nucleotide variants, short insertions/deletions, copy number variations, and chromosomal arm aneuploidy, emphasizing subtype-specific architectures. Tumor-relevant variants occur in 74.5%, including germline predisposition variants and frequent somatic mutations. Many cases show therapeutic targets or guideline-recommended biomarkers, with tumor-type chromosomal instability patterns and adult-divergent mutational profiles.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/integrative-genomic-profiling-of-pediatric-solid-tumors-reveals-clinically-relevant-variants-and-chromosomal-arm-aneuploidies-signatures/355191/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/integrative-genomic-profiling-of-pediatric-solid-tumors-reveals-clinically-relevant-variants-and-chromosomal-arm-aneuploidies-signatures/355191.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What types of genomic alterations were analyzed in the study?","Question",{"text":63,"@type":64},"The study used targeted next-generation sequencing to assess single nucleotide variants, short insertions/deletions, copy number variations, and chromosomal arm-level aneuploidy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How frequently were tumor-relevant variants detected?",{"text":68,"@type":64},"Tumor-relevant variants were identified in 74.5% of cases, including germline predisposition variants and somatic mutations.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the study find regarding clinical actionability?",{"text":72,"@type":64},"A substantial proportion of tumors (58.5%) harbored therapeutic targets or guideline-recommended biomarkers, supporting molecularly guided precision therapeutic strategies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355191,1790189289,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Cancer Medicine  \n|  RESEARCH ARTICLE  OPEN ACCESS \u003Cbr>Integrative Genomic Profiling of Pediatric Solid Tumors Reveals Clinically Relevant Variants and Chromosomal Arm Aneuploidies Signatures\u003Cbr>Bingxiao Yan1,2,3,4  | Jinhu Wang1,3,4,5,6 | Jieni Xiong1,4 | Shuangai Liu1,4 | Yinbing Tang1,4 | Ziqi He1,4 | Hujin Yan1,4 | Bize Guo1,4 | Chen Chen1,4 | Yijie Zhang4,7 | Qinfang Zhu1,4 | Jiabin Cai1,4  | Min He1,4 | Xuan Wu1,4 | Junqing Mao1,4  | Lifeng Zhang1,4 | Weizhong Gu8 | Zhu Zhu9,10 | Zheming Li9,10  | Rui Xiao2,3 | Qiang Shu3,4,5 | Gang Yu9,10  |\u003Cbr>Ting Tao1,3,4,5,6\u003Cbr>1Department of Surgical Oncology, Children's Hospital Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, Hangzhou, Zhejiang, China | 2Biosan (Hangzhou) Clinical Laboratory, Hangzhou, Zhejiang, China | 3Child Health Innovation Research Center, Binjiang Institute of Zhejiang University, Hangzhou, Zhejiang, China | 4Pediatric Cancer Research Center, National Clinical Research Center for Children and Adolescents' Health and Diseases, Children's Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China | 5Zhejiang Key Laboratory of Neonatal Diseases, Children's Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China | 6Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China | 7Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, China | 8Department of Pathology, Children's Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China | 9National Clinical Research Center for Children and Adolescents' Health and Diseases, National Children's Regional Medical Center, Children's Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China | 10Sino-Finland Joint AI Laboratory for Child Health of Zhejiang Province, Hangzhou, Zhejiang, China\u003Cbr>Correspondence: Gang Yu ([yugbme@zju.edu.cn](yugbme@zju.edu.cn)) | Ting Tao ([taot@zju.edu.cn](taot@zju.edu.cn))\u003Cbr>Received: 7 April 2025 | Revised: 10 December 2025 | Accepted: 12 February 2026\u003Cbr>Keywords: chromosome arm aneuploidies | clinically relevant variants | germline predisposition variants | pediatric solid tumors |\n| --- |\n| ABSTRACT\u003Cbr>Background: Pediatric malignancies have emerged as the leading cause of disease-related mortality in children, exhibiting distinct etiological and molecular characteristics compared to adult cancers. Despite advances in genomic profiling, the molecular landscape of pediatric solid tumors, particularly in Chinese populations, remains undercharacterized.\u003Cbr>Methods: Through targeted next-generation sequencing of 94 pediatric solid tumors, we systematically analyzed single nucleotide variants, short insertions/deletions, copy number variations, and chromosomal arm-level aneuploidy, with particular emphasis on subtype-specific genomic architectures.\u003Cbr>Results: Tumor relevant variants were identified in 74.5% of cases, comprising germline predisposition variants (17.0%) with higher prevalence in blastomas and somatic mutations (71.3%) . Remarkably, 58.5% harbored therapeutic targets or guidelinerecommended biomarkers, providing molecular rationales for precision therapeutic strategies. Key findings revealed tumor-type specific chromosomal instability patterns: sarcoma-characteristic chromosome 8 gains, neuroblastoma-enriched 17q amplifications, and TP53 mutations co-occurring with 1q gains—a profile divergent from adult malignancies.\u003Cbr>Conclusion: This study establishes the most comprehensive genomic atlas of Chinese pediatric solid tumors to date, delineating subtype-specific oncogenic variants and chromosomal instability signatures. Our findings advance the understanding of childhood cancer pathogenesis and provide a framework for molecularly guided clinical decision-making. |\n|  |\n| Bingxiao Yan, Jinhu Wang, and Jieni Xiong contributed equally to this work. |\n| This is an open access article und","cbCaikwSrbqlfedI","https://ap.wps.com/l/cbCaikwSrbqlfedI","pdf",1625296,13,"English","# Introduction\n## Pediatric malignancies and epidemiology\n## Biological and clinical distinctions from adult cancers\n# Methods and genomic profiling (from abstract)\n## Targeted next-generation sequencing design\n## Variant and aneuploidy analysis\n# Results (from abstract)\n## Tumor-relevant variants and germline predisposition\n## Therapeutic targets or guideline biomarkers\n## Tumor-type chromosomal instability signatures\n# Conclusion (from abstract)\n## Comprehensive genomic atlas and clinical implications","[{\"question\":\"What types of genomic alterations were analyzed in the study?\",\"answer\":\"The study used targeted next-generation sequencing to assess single nucleotide variants, short insertions/deletions, copy number variations, and chromosomal arm-level aneuploidy.\"},{\"question\":\"How frequently were tumor-relevant variants detected?\",\"answer\":\"Tumor-relevant variants were identified in 74.5% of cases, including germline predisposition variants and somatic mutations.\"},{\"question\":\"What did the study find regarding clinical actionability?\",\"answer\":\"A substantial proportion of tumors (58.5%) harbored therapeutic targets or guideline-recommended biomarkers, supporting molecularly guided precision therapeutic strategies.\"}]","Integrative Genomic Profiling of Pediatric Solid Tumors Reveals Clinically Relevant Variants and Chromosomal Arm Aneuploidies Signatures | PDF",1790116620,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aceadb7083003f7e2bad51821229d04f.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52a08509828275e961dfd977ad5ab855.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41846c626470b008b432820a0696961f.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e950b12a46b39a85117d15710cb69ccc.webp",980,1287]